Evidence map›Paper›PMID 34830713›Full record

ArticleJournal of clinical medicine2021

Exploring Consensus on Preventive Measures and Identification of Patients at Risk of Age-Related Macular Degeneration Using the Delphi Process.

Alfredo García-Layana, Gerhard Garhöfer, Tariq M Aslam, Rufino Silva, Cécile Delcourt, Caroline C W Klaver, Johanna M Seddon, Angelo M Minnella

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alfredo García-LayanaClínica Universidad de Navarra, IdiSNA (Instituto de Investigación Sanitaria de Navarra), 31009 Pamplona, Spain.
Gerhard GarhöferDepartment of Clinical Pharmacology, Medical University of Vienna, 1090 Wien, Austria.
Tariq M AslamSchool of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.ORCID 0000-0002-9739-7280
Rufino SilvaFaculty of Medicine, Institute for Clinical and Biomedical Research (ICBR-FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.ORCID 0000-0001-8676-0833
Cécile DelcourtUniversity Bordeaux, Inserm, Bordeaux Population Health Research Center, Team LEHA, UMR 1219, F-33000 Bordeaux, France.ORCID 0000-0002-2099-0481
Caroline C W KlaverDepartment Ophthalmology, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands.
Johanna M SeddonDepartment of Ophthalmology and Visual Sciences, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Angelo M MinnellaUOC Oculistica, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.ORCID 0000-0001-5896-5313

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly identification of AMD can lead to prompt and more effective treatment, better outcomes, and better final visual acuity; several risk scores have been devised to determine the individual level of risk for developing AMD. Herein, the Delphi method was used to provide recommendations for daily practice regarding preventive measures and follow-up required for subjects at low, moderate, and high risk of AMD evaluated with the Simplified Test AMD Risk-assessment Scale (STARS

methodsA steering committee of three experts drafted and refined 25 statements on the approach to be recommended in different clinical situations [general recommendations (

resultsIn the first round of voting, consensus was reached for 24 statements. After modification, consensus was then reached for the remaining statement.

conclusionAn interprofessional guideline to support preventive measures in patients at risk of AMD based on STARS

Indexed as

age-related macular degenerationDelphifood supplementidentificationpreventionriskSTARS®

Identifiers

PMID34830713
PMCPMC8623425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.